Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


1 Am J Cardiol
1 Basic Res Cardiol
1 Circ Arrhythm Electrophysiol
1 Circ Heart Fail
5 Circulation
19 Eur J Heart Fail
3 Heart
1 Hypertension
1 Int J Cardiol
4 J Am Coll Cardiol
2 J Card Fail
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Cardiol

  1. MEFFORD MT, Sephel A, Van Dyke MK, Chen L, et al
    Medication-Taking Behaviors and Perceptions Among Adults With Heart Failure (from the REasons for Geographic And Racial Differences in Stroke Study).
    Am J Cardiol. 2019 Feb 23. pii: S0002-9149(19)30229.
    PubMed     Text format     Abstract available

    Basic Res Cardiol

  2. BACMEISTER L, Schwarzl M, Warnke S, Stoffers B, et al
    Inflammation and fibrosis in murine models of heart failure.
    Basic Res Cardiol. 2019;114:19.
    PubMed     Text format     Abstract available

    Circ Arrhythm Electrophysiol

    What Have We Learned From Randomized Controlled Trials of Catheter Ablation for Atrial Fibrillation in Patients With Chronic Heart Failure?
    Circ Arrhythm Electrophysiol. 2019;12:e007222.
    PubMed     Text format    

    Circ Heart Fail

  4. Correction to: Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling.
    Circ Heart Fail. 2019;12:e000035.
    PubMed     Text format    


  5. VERMA S, McMurray JJV
    The Serendipitous Story of SGLT2 Inhibitors in Heart Failure: New Insights from DECLARE-TIMI 58.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.040514.
    PubMed     Text format     Abstract available

  6. KATO ET, Silverman MG, Mosenzon O, Zelniker TA, et al
    Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.040130.
    PubMed     Text format     Abstract available

  7. FIGTREE GA, Radholm K, Barrett TD, Perkovic V, et al
    Effects of Canagliflozin on Heart Failure Outcomes Associated with Preserved and Reduced Ejection Fraction in Type 2 Diabetes: Results from the CANVAS Program.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040057.
    PubMed     Text format     Abstract available

  8. BOTS SH, den Ruijter HM
    Recommended Heart Failure Medications and Adverse Drug Reactions in Women.
    Circulation. 2019;139:1469-1471.
    PubMed     Text format    

  9. NIELSEN R, Moller N, Gormsen LC, Tolbod LP, et al
    Cardiovascular Effects of Treatment with the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.
    Circulation. 2019 Mar 19. doi: 10.1161/CIRCULATIONAHA.118.036459.
    PubMed     Text format     Abstract available

    Eur J Heart Fail

  10. RICHARDS AM, Pemberton C, Yandle T
    How does neprilysin inhibition in heart failure work?
    Eur J Heart Fail. 2019 Mar 18. doi: 10.1002/ejhf.1454.
    PubMed     Text format    

  11. GHAFOURIAN K, Chang HC, Ardehali H
    Intravenous iron therapy in heart failure: a different perspective.
    Eur J Heart Fail. 2019 Mar 18. doi: 10.1002/ejhf.1434.
    PubMed     Text format    

  12. COATS AJS, Seferovic PM
    News from the American Heart Association: more on sodium-glucose co-transporter 2 inhibitors, diabetes and heart failure.
    Eur J Heart Fail. 2019;21:261-263.
    PubMed     Text format    

  13. METRA M
    Figures of the Heart Failure Association: Andrew J. Stewart Coats, President-Elect, 2018-2020.
    Eur J Heart Fail. 2019;21:269-271.
    PubMed     Text format    

  14. PAPADAKI A, Martinez-Gonzalez MA, Alonso-Gomez A, Rekondo J, et al
    Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial. Eur J Heart Fail 2017;19:1179-1185. doi: 10.1002/ejhf.750.
    Eur J Heart Fail. 2019;21:389-391.
    PubMed     Text format    

    Figures of the Heart Failure Association: Petar M. Seferovic, President, 2018-2020.
    Eur J Heart Fail. 2019;21:266-268.
    PubMed     Text format    

  16. AHMAD T, Freeman JV, Asselbergs FW
    Can advanced analytics fix modern medicine's problem of uncertainty, imprecision, and inaccuracy?
    Eur J Heart Fail. 2019;21:86-89.
    PubMed     Text format    

  17. MEHRA MR
    Evolving disruption in left ventricular assist systems: forgiving but not yet forgettable.
    Eur J Heart Fail. 2019;21:98-100.
    PubMed     Text format    

  18. LUND LH
    Improving long-term outcomes with left ventricular assist devices-referral, selection, experience, and technology.
    Eur J Heart Fail. 2019;21:101-102.
    PubMed     Text format    

  19. FERREIRA JP, Zannad F
    Patient-reported and morbidity-mortality endpoints: can one have the best of both worlds?
    Eur J Heart Fail. 2019;21:71-73.
    PubMed     Text format    

  20. GORI M, Redfield MM, Calabrese A, Canova P, et al
    Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg study.
    Eur J Heart Fail. 2018;20:1540-1548.
    PubMed     Text format     Abstract available

  21. SANDERS NA, Supiano MA, Lewis EF, Liu J, et al
    The frailty syndrome and outcomes in the TOPCAT trial.
    Eur J Heart Fail. 2018;20:1570-1577.
    PubMed     Text format     Abstract available

  22. AL-SAAIDI RA, Rasmussen TB, Birkler RID, Palmfeldt J, et al
    The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelope.
    Eur J Heart Fail. 2018;20:1404-1412.
    PubMed     Text format     Abstract available

  23. LINDE CM, Normand C, Bogale N, Auricchio A, et al
    Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II.
    Eur J Heart Fail. 2018;20:1457-1468.
    PubMed     Text format     Abstract available

  24. TRULLAS JC, Formiga F, Manzano L
    The use of thiazide and thiazide-like diuretics in heart failure with congestion.
    Eur J Heart Fail. 2019 Mar 20. doi: 10.1002/ejhf.1455.
    PubMed     Text format    

  25. BAVENDIEK U, Berliner D, Davila LA, Schwab J, et al
    Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study.
    Eur J Heart Fail. 2019 Mar 20. doi: 10.1002/ejhf.1452.
    PubMed     Text format     Abstract available

  26. MCMURRAY JJV, DeMets DL, Inzucchi SE, Kober L, et al
    A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).
    Eur J Heart Fail. 2019 Mar 21. doi: 10.1002/ejhf.1432.
    PubMed     Text format     Abstract available

  27. TEMPORELLI PL, Tilz RR, Arbelo E, Dagres N, et al
    Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association.
    Eur J Heart Fail. 2019 Mar 21. doi: 10.1002/ejhf.1458.
    PubMed     Text format    

  28. MULLENS W, Damman K
    Reply to letters on "The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology".
    Eur J Heart Fail. 2019 Mar 22. doi: 10.1002/ejhf.1462.
    PubMed     Text format    


  29. BUBER J, Valente AM
    Predicting survival in adults with congenital heart disease: what are the odds?
    Heart. 2018;104:1643-1644.
    PubMed     Text format    

  30. LARSSON SC, Drca N, Bjorck M, Back M, et al
    Nut consumption and incidence of seven cardiovascular diseases.
    Heart. 2018 Apr 16. pii: heartjnl-2017-312819. doi: 10.1136/heartjnl-2017-312819
    PubMed     Text format     Abstract available

  31. B SCHNABEL R, Pecen L, Engler D, Lucerna M, et al
    Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes.
    Heart. 2018 Mar 17. pii: heartjnl-2017-312569. doi: 10.1136/heartjnl-2017-312569
    PubMed     Text format     Abstract available


  32. FLEENOR BS, Ouyang A, Olver TD, Hiemstra JA, et al
    Saxagliptin Prevents Increased Coronary Vascular Stiffness in Aortic-Banded Mini Swine.
    Hypertension. 2018;72:466-475.
    PubMed     Text format     Abstract available

    Int J Cardiol

    Betaeta-blocker therapy in cocaine-associated heart failure: Attempting to mitigate the risk.
    Int J Cardiol. 2019;283:135.
    PubMed     Text format    

    J Am Coll Cardiol

  34. SHAH RV, Das S, Lewis GD
    Circulating MicroRNAs: New Avenues for Heart Failure Classification?
    J Am Coll Cardiol. 2019;73:1314-1316.
    PubMed     Text format    

  35. WONG LL, Zou R, Zhou L, Lim JY, et al
    Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes.
    J Am Coll Cardiol. 2019;73:1300-1313.
    PubMed     Text format     Abstract available

  36. ANAND IS
    What Explains the Benefits of ARNI Therapy in Heart Failure?
    J Am Coll Cardiol. 2019;73:1285-1287.
    PubMed     Text format    

  37. ARNOLD SV, Chinnakondepalli KM, Spertus JA, Magnuson EA, et al
    Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.
    J Am Coll Cardiol. 2019 Mar 4. pii: S0735-1097(19)30505.
    PubMed     Text format     Abstract available

    J Card Fail

  38. ABU-SALEH N, Aronson D, Khamaisi M, Khoury E, et al
    Increased intra-abdominal pressure induces acute kidney injury in experimental model of congestive heart failure.
    J Card Fail. 2019 Mar 14. pii: S1071-9164(18)30330.
    PubMed     Text format     Abstract available

    Heart Failure Practice in Japan: Successful at Present, but Challenging in the Future.
    J Card Fail. 2019;25:145-146.
    PubMed     Text format    

    PLoS One

  40. OYENUGA AO, Couper D, Matsushita K, Boerwinkle E, et al
    Association of monocyte myeloperoxidase with incident cardiovascular disease: The Atherosclerosis Risk in Communities Study.
    PLoS One. 2018;13:e0205310.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.